Astrocytic tumors, low-grade: General considerations

Brain and Spinal Tumors of Childhood

Volumn , Issue , 2004, Pages 245-258

  Gnekow, Astrid K ^a   Packer, Roger J ^b   Kortmann, Rolf D ^c  

^a Hospital for Children and Adolescents   (Germany)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057928247     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Stiller C, Nectoux J. International incidence of childhood brain and spinal tumours. Int J Epidemiol 1994; 23:458-64.
2. Bernards A. Neurofibromatosis type I and ras-mediated signaling: Filling in the GAP's. Biochim BiophysActa 1995; 1242:43-59.
3. Shen M, Harper P, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 33:2-17.
4. Riccardi V. Histogenesis control genes and neurofibromatosis 1. Eur J Pediatr 2000; 159:475-6.
5. Riccardi V. Neurofibromatosis: Past, present and future. N Engl J Med 1991; 324:1283-5.
6. Riccardi V. Neurofibromatosis: Phenotype, natural history and pathogenesis. Baltimore, MD: Johns Hopkins University Press, 1992.
7. Lewis R, Gerson L, Axelson K, Riccardi V, Whitford R. Von Recklinghausen neurofibromatosis II. Incidence of optic gliomata. Ophthalmology 1984; 91:929-35.
8. Listernick R, Louis D, Packer R, Gutmann D. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NFA Optic Pathway Glioma Task Force. Ann Neurol 1997; 41:143-9.
9. Vinchon M, Soto-Ares G, Ruchoux M, Dhellemmes P. Cerebellar gliomas in children with NF1: Pathology and surgery. Childs Nerv Syst 2000; 16:417-20.
10. Capelli C, Grill J, Raquin M, etal. Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child 1998; 79:334-8.
11. Castello M, Schiavetti A, Varrasso G, Clerico A, Capelli C. Chemotherapy in low-grade astrocytoma management. Childs Nerv Syst 1998; 14:6-9.
12. Dutton J. Gliomas of the anterior visual pathway. Surv Ophthalmol 1994; 38:427-52.
13. Packer R, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997; 86:747-54.
14. Friedman J, Birch P. An association between optic glioma and other tumors of the central nervous system in neurofibromatosis type I. Neuropediatrics 1997; 28:131-2.
15. Roach E, Gomez M, Northrup H. Tuberous sclerosis complex consensus conference: Revised diagnostic criteria. J Child Neurol 1998; 13:624-8.
16. Jozwiak S, Schwartz R, Janniger C, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000; 15:652-9.
17. Li F, Fraumeni JJ. Prospective study of a family cancer syndrome. J Am Med Assoc 1982; 247:2692-4.
18. Lynch H, Katz D, Bogard P, Lynch J. The sarcoma, breast cancer, lung cancer and adrenocortical carcinoma syndrome revisited: Childhood cancer. Am J Dis Child 1985; 139:134-6.
19. Malkin D, Li F, Strong L, etal. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250:1233-8.
20. Ohgaki K, Vital A, Kleihues P, Hainaut P. Li-Fraumeni syndrome and TP53 germline mutations. In: Kleihues P, Cavenee W (eds). Pathology and Genetics: Tumors of the Nervous System. Lyon: Iarc Press, 2000, pp. 231-4.
21. Amirjamshidi A, Abbassioun K. Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Childs NervSyst 2000; 16:390-7.
22. Shore R, Albert R, Pasternack B. Follow up study of patients treated by x-ray epilation for tinea capitis. Arch Environ Health 1976; 31:21-8.
23. Miettinen H, Kononen J, Sallinen P, et al. CDKN2/p16 predicts survival in oligodendrogliomas: Comparison with astrocytomas. J Neuro-Oncol 1999; 41:205-11.
24. Smith J, Perry A, Borell T, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas. J Clin Oncol 2000; 18:636-45.
25. Von Deimling A, Louis D, Menon A, Ellison D, Wiestler O, Seizinger B. Allelic loss on the long arm of chromosome 17 in pilocytic astrocytoma. Acta Neuropathol 1993; 86:81 -5.
26. Ohgaki K, Schauble B, zur Hausen A, von Ammon K, Kleihues P. Genetic alterations associated with the evolution and progression of astrocytic brain tumors. Virchows Arch 1995; 427:113-18.
27. Mathew P, Look T, Luo X, et al. DNA index of glial tumors in children. Correlation with tumor grade and prognosis. Cancer1996; 78:881-6.
28. Bodey B, Bodey BJ, Siegel S, Kaiser H. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? In Vivo 1999; 13:357-74.
29. Von Bossanyi P, Sallaba J, Dietzmann K, Warich-Kirches M, Kirches E. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic glioma. Pathol Res Pract 1998; 194:141-7.
30. Rhodes R. Biological evaluation of biopsies from adult cerebral astrocytomas: Cell growth/cell suicide ratios and their relationship to patient survival. J Neuropathol Exp Neurol1998; 57:746-57.
31. Abdulrauf S, Edvardsen K, Ho K, Yang X, Rock J, Rosenblum M. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998; 88:513-20.
32. Hoshi M, Yoshida K, Shimazaki K, Sasaki H, Otani M, Kawase T. Correlation between MIB 1-staining indices and recurrence in low-grade astrocytomas. Brain Tumor Pathol 1997; 14:47-51.
33. Sasaki H, Yoshida K, Ikeda E, et al. Expression of the neural cell adhesion molecule in astrocytic tumors: An inverse correlation with malignancy. Cancer 1998; 82:1921-31.
34. Prados M, Krouwer H, Edwards M, Cogen P, Davis R, Hoshino T. Proliferative potential and outcome in pediatric astrocytic tumors. J Neuro-Oncol 1992; 13:277-82.
35. Cattoretti G, Becker M, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168:357-63.
36. Burger P, Shibata T, Kleihues P. The use of monoclonal antibody Ki 67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 1986; 10:611-17.
37. Dirven C, Kondstaal J, Mooij J, Molenaar W. The proliferative potential of the pilocytic astrocytoma: The relation between MIB-1 labeling and clinical and neuro-radiological follow-up. J Neuro-Oncol 1998; 37:9-16.
38. Cummings T, Provenzale J, Hunter S, et al. Gliomas of the optic nerve: Histological, immunohistochemical (MIB-1 and p53) and MRI analysis. Acta Neuropathol 2000; 99:563-70.
39. Czech T, Slavc I, Aichholzer M, et al. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children. J Neuro-Oncol 1999; 42:143-50.
40. Ishii N, Tada M, Hamou M, et al. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene 1999; 18:5870-8.
41. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum M, Cavenee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 1992; 355:846-7.
42. Hayes V, Dirven C, Dam A, et al. High frequency of TP43 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors. Brain Pathol 1999; 9:463-7.
43. Albright A, Price R, Guthkelch A. Diencephalic gliomas of children. Cancer 1985; 55:2789-93.
44. Pollack I. The role of surgery in pediatric gliomas. J Neuro-Oncol 1999; 42:271-88.
45. Berger M, Deliganis A, Dobbins J, Keles G. The effect of extent of resection on recurrence in patients with low grade cerebral hemispheric gliomas. Cancer 1994; 74:1784-91.
46. So E. Integration of EEG, MRI and SPECT in localizing the seizure focus for epilepsy surgery. Epilepsia 2000; 41 (suppl. 3):S48-54.
47. Coakley K, Huston JI, Scheithauer B, Forbes G, Kelly P. Pilocytic astrocytomas: Well demarcated magnetic resonance appearance despite frequent infiltration histologically. Mayo Clin Proc1995; 70:747-51.
48. Hirsch J-F, Rose C, Pierre-Kah A, Pfister A, Hoppe-Hirsch E. Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J Neurosurg 1989; 70:568-72.
49. Smoots D, Geyer J, Lieberman D, Berger M. Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst 1998; 14:636-48.
50. Pollack I, Claassen D, Al-Shboul Q, Janosky J, Deutsch M. Low-grade gliomas of the cerebral hemispheres In children: An analysis of 71 cases. J Neurosurg 1995; 82:536-47.
51. West C, Gattamaneni R, Blair V. Radiotherapy in the treatment of low grade astrocytomas I. A survival analysis. Childs Nerv Syst 1995; 11:438-42.
52. Wallner K, Gonzales M, Edwards M, Wara W, Sheline G. Treatment results of juvenile pilocytic astrocytoma. J Neurosurg 1988; 69:171-6.
53. Campbell J, Pollack I. Cerebellar astrocytomas in children. J Neuro-Oncol 1996; 28:223-31.
54. Gjerris F, Klinken L. Long term prognosis in children with benign cerebellar astrocytoma. J Neurosurg 1978; 49:179-84.
55. Pencalet P, Maixner W, Sainte-Rose C, etal. Benign cerebellar astrocytomas in children. J Neurosurg 1999; 90:265-73.
56. Garvey M, Packer R. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neuro-Oncol 1996; 28:167-83.
57. Hoffman H, Soloniuk D, Humphryes R, et al. Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. Neurosurgery 1993; 33:964-71.
58. Sutton L, Molloy P, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995; 83:583-9.
59. Janss A, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995; 75:1051 -9.
60. Wisoff J, Abbott R, Epstein F. Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 1990; 73:661-7.
61. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A. Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: A real possibility. J Child Neurol 1999; 14:352-6.
62. Kernan J, Horgan M, Piatt J, D'Agostino A. Spontaneous involution of a diencephalic astrocytoma. Pediatr Neurosurg1998; 29:149-53.
63. Schmandt S, Packer R, Vezina L, Jane J. Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 2000; 32:132-6.
64. Takeuchi H, Kabuto M, Sato K, Kubota T. Chiasmal gliomas with spontaneous regression: Proliferation and apoptosis. Childs Nerv Syst 1997; 13:229-33.
65. Forsyth P, Shaw E, Scheithauer B, O'Fallon J, Layton DJ, Katzman J. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic and flow cytometric study of 51 patients. Cancer 1993; 72:1335-42.
66. Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: Surveillance, resection or irradiation? Int J Radiat Oncol Biol Phys 1993; 25:215-25.
67. Shaw E, Daumas-Duport C, Scheithauer B, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70:853-61.
68. Shibamato Y, Kitakabu Y, Takahashi M, et al. Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 1993; 72:190-5.
69. Kortmann R, Zanetti I, Mueller S, et al. Radiotherapy in low grade glioma: An interim analysis of the SIOP low grade glioma study. In: Proceedings of the IXth Symposium Pediatric NeuroOncology, San Francisco, 2000.
70. Kortmann R, Tlmmermann B, Becker G, Kuehl J, Bamberg M. Advances In treatment techniques and tlme/dose schedules In external radiation therapy of brain tumours In childhood. Klin Pediatr 1998; 210:220-6.
71. Pollack I, Hurtt M, Pang D, Albright A. Dissemination of low grade intracranial astrocytomas in children. Cancer 1994; 73:2869-78.
72. Bataini J, Delanian S, Ponvert D. Chiasmal gliomas: Results of irradiation management in 57 patients and review of the literature. Int J Radiat Oncol Biol Phys 1991; 21:615-23.
73. Grabenbauer G, Schuchardt U, Buchfelder M, et al. Radiation therapy of optico-hypothalamic gliomas (OHG) - radiographic response, vision and toxicity. Radiother Oncol 2000; 54:239-45.
74. Bakardjiev A, Barnes P, Goumnerova L, et al. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer 1996; 78:864-73.
75. Benk V, Clark B, Souhami L, et al. Stereotactic radiation in primary brain tumors in children and adolescents. Paediatr Neurosurg 1999; 31:59-64.
76. Debus J, Kocagoncu K, Hoss A, Wenz F, Wannenmacher M. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 1999; 44:243-8.
77. Ganz J, Smievoll A, Thorsen F. Radiosurgical treatment of gliomas of the diencephalon. Acta Neurochir 1994; 62 (suppl.):62-6.
78. Grabb P, Lunsford L, Albright A, Kondziolka D, Flickinger J. Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 1996; 38:696-702.
79. Lim Y, Leem W. Two cases of gamma knife radiosurgery for low-grade optic chiasm glioma. Stereotact Funct Neurosurg1996; 66 (suppl. 1):174-83.
80. Somaza S, Kondziolka D, Lunsford L, Flickinger J, Bissonette D, Albright A. Early outcomes after stereotactic radiosurgery for growing pilocytic astrocytomas in children. Pediatr Neurosurg1996; 25:109-15.
81. Tarbell N, Loeffler J. Recent trends in the radiotherapy of pediatric gliomas. J Neuro-Oncol 1996; 28:233-44.
82. Aquino V, Fort D, Kamen B. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: A phase II study. J Neuro-Oncol 1999; 41:255-9.
83. Chamberlain M, Grafe M. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 1995; 13:2072-6.
84. Chamberlain M. Recurrent cerebellar gliomas: Salvage therapy with oral etoposide. J Child Neurol 1997; 12:200-4.
85. Friedman H, Krischer J, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 1992; 10:249-56.
86. McCowage G, Longee D, Fuchs H, Friedman H. Treatment of high-grade gliomas and metastatic pilocytic astrocytomas with high-dose cyclophosphamide. In: Proceedings of the Annual Meeting of the American Society of Clinical Oncologists, 1995, p. A290.
87. Moghrabi A, Friedman H, Burger P, Tien R, Oakes W. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 1993; 79:223-7.
88. Kadota R, Kun L, Langston J, et al. Cyclophosphamide for the treatment of progressive low-grade astrocytoma: A Paediatric Oncology Group phase II study. J Pediatr Hematol Oncol 1999; 21:198-202.
89. Rosenstock J, Evans A, Schut L. Response to vincristine of recurrent brain tumors in children. J Neurosurg 1976; 45:135-40.
90. Heideman R, Douglass E, Langston J, et al. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: A Pediatric Oncology Group study. J Neuro-Oncol1995; 25:77-84.
91. Mulne A, Ducore J, Elterman R, et al. Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group study. J Pediatr Hematol Oncol 2000; 22:41-4.
92. Blaney S, Phillips P, Packer R, et al. Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer 1996; 78:527-31.
93. Kadota R, Stewart C, Horn M, et al. Topotecan for the treatment of progressive central nervous system tumors: A Pediatric Oncology Group phase II study. J Neuro-Oncol1999; 43:43-7.
94. Packer R, Sutton L, Bilaniuk L, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 1988; 23:79-85.
95. Packer R, Lange B, Ater J, et al. Carboplatin and vincristine for progressive low-grade gliomas of childhood. J Clin Oncol1993; 11:850-7.
96. Perilongo G, Walker D, Taylor R, et al. Vincristine (VCR) carboplatin (CBDCA) in hypothalamic-chiasmatic low grade glioma (HC-LGG). SIOP-LGG study report. Med Pediatr Oncol2000; 35:190.
97. Gnekow A, Kaatsch P, Kortmann R, Wiestler O. HIT-LGG: Effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood: An interim report. Klin Pediatr2000; 212:177-84.
98. Castello M, Schiavetti A, Padula A, et al. Does chemotherapy have a role in low-grade glioma management? Med Pediatr Oncol 1995; 25:102-8.
99. Pons M, Finlay J, Walker R, Puccetti D, Packer R, McElwain M. Chemotherapy with vincristine and etoposide in children with low-grade astrocytoma. J Neuro-Oncol 1992; 14:151-8.
100. Petronio J, Edwards M, Prados M, et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 1991; 74:701 -8.
101. Prados M, Edwards M, Rabbitt J, Lamborn K, Davis R, Levin V. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-Oncol1997; 32:235-41.
102. Doireau V, Grill J, Zerah M, et al. Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Sub-committee of the French Society of Pediatric Oncology (SFOP). Br J Cancer 1999; 81:835-40.
103. Grill J, Laithier V, Rodriguez D, Raquin M, Pierre-Kahn A, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 2000; 159:692-6.
104. Souweidane M, Hoffman H. Current treatment of thalamic gliomas in children. J Neuro-Oncol 1996; 28:157-66.
105. Grill J, Couanet D, Capelli C, et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 1999; 45:393-6.
106. Montgomery A, Griffin T, Parker R, Gerdes A. Optic nerve glioma: The role of radiation therapy. Cancer 1977; 40:2079-80.
107. Danoff B, Kramer S, Thompson N. The radiotherapeutic management of optic gliomas of children. Int J Radiat Oncol Biol Phys 1980; 6:45-50.
108. Sung D. Suprasellar tumors in children: A review of clinical manifestations and managements. Cancer 1982; 50:1420-5.
109. Horwich A, Bloom H. Optic gliomas: Radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 1985; 11:1067-79.
110. Wong J, Uhl V, Wara W, Sheline G. Optic gliomas. A re-analysis of the University of California, San Francisco, experience. Cancer 1987; 60:1847-55.
111. Weiss L, Sagerman R, King G, Chung C, Dubowy R. Controversy in the management of optic nerve glioma. Cancer 1987; 59:1000-4.
112. Flickinger J, Torres C, Deutsch M. Management of low grade gliomas of the optic nerve and chiasm. Cancer 1988; 61:635-42.
113. Kovalic J, Grigsby P, Shepard M, Fineberg B, Thomas P. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 1990; 18:927-32.
114. Pierce S, Barnes P, Loeffler J, McGinn C, Tarbell N. Definitive radiation therapy in the management of symptomatic patients with optic glioma. Cancer 1990; 65:45-52.
115. Erkal H, Serin M, Cakmak A. Management of optic pathway and chiasmatic-hypothalamic gliomas in children: Tumor volume response to radiation therapy. Radiother Oncol 1997; 45:11-15.
116. Gajjar A, Sanford R, Heideman R, et al. Low-grade astrocytoma: A decade of experience at St Jude Children's Research Hospital. J Clin Oncol 1997; 15:2792-9.
117. Fisher B, Bauman G, Leighton C, Stitt L, Cairncross J, Macdonald D. Low-grade gliomas in children: Tumor volume response to radiation. J Neurosurg 1998; 88:969-74.
118. Karim A, Maat B, Hatlevoll R, et al. A randomised trial of dose-response in radiation therapy of low-grade cerebral glioma: European Organisation for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys1996; 36:263-70.
119. Alvord EJ, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site and treatment. J Neurosurg 1988; 68:85-98.
120. Dunbar S, Tarbell N, Kooy H, et al. Stereotactic radiotherapy for pediatric and adult brain tumors: Preliminary report. Int J Radiat Oncol Biol Phys 1994; 30:531-9.
121. McCowage G, Tien R, McLendon R, et al. Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 1996; 27:32-9.
122. Longee D, Friedman H, Albright R, et al. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 1990; 72:583-8.
123. Laithier V, Raquin M, Couanet D, et al. Chemotherapy for children with optic pathway glioma: Results of a prospective study by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 2000; 35:190.